Option Care Health (NASDAQ: OPCH) insider transactions
In the twelve months to 10 November 2026, executives and directors of Option Care Health reported 2 open-market sales of 36,287 shares ($1.2m) and 4 open-market purchases of 89,489 shares ($1.9m), by 6 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 6 July 2026 | Bhatia Prateek | EVP Sp Sales & Solutions | Grant or award | +16,386 | — | 16,386 | Form 4 |
| 6 July 2026 | Bhatia Prateek | EVP Sp Sales & Solutions | Grant or award | +23,409 | — | 39,795 | Form 4 |
| 20 May 2026 | Brandt Eric | Director | Grant or award | +8,997 | — | 19,356 | Form 4 |
| 20 May 2026 | Brandt Eric | Director | Grant or award | +2,643 | $22.23 | 21,999 | Form 4 |
| 20 May 2026 | Wright Norman L. | Director | Grant or award | +8,997 | — | 24,498 | Form 4 |
| 20 May 2026 | Bodem Barbara W. | Director | Grant or award | +8,997 | — | 21,087 | Form 4 |
| 20 May 2026 | Sullivan Timothy P | Director | Grant or award | +8,997 | — | 82,380 | Form 4 |
| 20 May 2026 | Sullivan Timothy P | Director | Grant or award | +4,836 | $22.23 | 87,216 | Form 4 |
| 20 May 2026 | Pate R Carter | Director | Grant or award | +8,997 | — | 20,620 | Form 4 |
| 20 May 2026 | Kraemer Harry M Jansen JR | Director | Grant or award | +8,997 | — | 458,997 | Form 4 |
| 20 May 2026 | Kraemer Harry M Jansen JR | Director | Grant or award | +12,079 | $22.23 | 471,076 | Form 4 |
| 20 May 2026 | Deckmann Natasha | Director | Grant or award | +8,997 | — | 31,158 | Form 4 |
| 20 May 2026 | Deckmann Natasha | Director | Grant or award | +844 | $22.23 | 32,002 | Form 4 |
| 20 May 2026 | Bierbower Elizabeth D | Director | Grant or award | +8,997 | — | 32,871 | Form 4 |
| 19 May 2026 | Smyser Collin | GC & Corporate Secretary | Option exercise | +812 | — | 75,372 | Form 4 |
| 19 May 2026 | Smyser Collin | GC & Corporate Secretary | Shares withheld for tax | −360 | $20.86 | 75,012 | Form 4 |
| 7 May 2026 | Sullivan Timothy P | Director | Open-market purchase | +24,154 | $20.69 | 73,383 | Form 4 |
| 4 May 2026 | Kraemer Harry M Jansen JR | Director | Open-market purchase | +36,610 | $21.41 | 450,000 | Form 4 |
| 4 May 2026 | Rademacher John Charles | Chief Executive Officer | Open-market purchase | +12,500 | $21.18 | 695,152 | Form 4 |
| 4 May 2026 | Sethna Meenal | Chief Financial Officer | Open-market purchase | +16,225 | $20.16 | 98,337 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Option Care Health page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.